Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hatice Gulcin Ozer

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Neuron|September 11, 2012
JNK3 perpetuates metabolic stress induced by Aβ peptidesSung Ok Yoon, Dong Ju Park, Jae Cheon Ryu, et al.
Blood Advances|November 30, 2021
Molecular, clinical, and prognostic implications of PTPN11 mutations in acute myeloid leukemiaSydney Fobare, Jessica Kohlschmidt, Hatice Gulcin Ozer, et al.
Blood Advances|March 8, 2021
Gene expression signature predicts relapse in adult patients with cytogenetically normal acute myeloid leukemiaChristopher J Walker, Krzysztof Mrózek, Hatice Gulcin Ozer, et al.
Cancers|June 10, 2023
Follicular Helper and Regulatory T Cells Drive the Development of Spontaneous Epstein-Barr Virus Lymphoproliferative DisorderElshafa Hassan Ahmed, Mark Lustberg, Claire Hale, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 2017
Prognostic and biological significance of the proangiogenic factor EGFL7 in acute myeloid leukemiaDimitrios Papaioannou, Changxian Shen, Deedra Nicolet, et al.
Nature Communications|November 4, 2021
Rare t(X;14)(q28;q32) translocation reveals link between MTCP1 and chronic lymphocytic leukemiaJanek S Walker, Zachary A Hing, Steven Sher, et al.
Journal of Hematology & Oncology|January 16, 2021
Recurrent XPO1 mutations alter pathogenesis of chronic lymphocytic leukemiaJanek S Walker, Zachary A Hing, Bonnie Harrington, et al.
The New England Journal of Medicine|May 30, 2014
Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinibJennifer A Woyach, Richard R Furman, Ta-Ming Liu, et al.
Cancer Discovery|February 2, 2018
BRD4 Profiling Identifies Critical Chronic Lymphocytic Leukemia Oncogenic Circuits and Reveals Sensitivity to PLX51107, a Novel Structurally Distinct BET InhibitorHatice Gulcin Ozer, Dalia El-Gamal, Ben Powell, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Neuron|September 11, 2012
JNK3 perpetuates metabolic stress induced by Aβ peptidesSung Ok Yoon, Dong Ju Park, Jae Cheon Ryu, et al.
Blood Advances|November 30, 2021
Molecular, clinical, and prognostic implications of PTPN11 mutations in acute myeloid leukemiaSydney Fobare, Jessica Kohlschmidt, Hatice Gulcin Ozer, et al.
Blood Advances|March 8, 2021
Gene expression signature predicts relapse in adult patients with cytogenetically normal acute myeloid leukemiaChristopher J Walker, Krzysztof Mrózek, Hatice Gulcin Ozer, et al.
Cancers|June 10, 2023
Follicular Helper and Regulatory T Cells Drive the Development of Spontaneous Epstein-Barr Virus Lymphoproliferative DisorderElshafa Hassan Ahmed, Mark Lustberg, Claire Hale, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 2017
Prognostic and biological significance of the proangiogenic factor EGFL7 in acute myeloid leukemiaDimitrios Papaioannou, Changxian Shen, Deedra Nicolet, et al.
Nature Communications|November 4, 2021
Rare t(X;14)(q28;q32) translocation reveals link between MTCP1 and chronic lymphocytic leukemiaJanek S Walker, Zachary A Hing, Steven Sher, et al.
Journal of Hematology & Oncology|January 16, 2021
Recurrent XPO1 mutations alter pathogenesis of chronic lymphocytic leukemiaJanek S Walker, Zachary A Hing, Bonnie Harrington, et al.
The New England Journal of Medicine|May 30, 2014
Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinibJennifer A Woyach, Richard R Furman, Ta-Ming Liu, et al.
Cancer Discovery|February 2, 2018
BRD4 Profiling Identifies Critical Chronic Lymphocytic Leukemia Oncogenic Circuits and Reveals Sensitivity to PLX51107, a Novel Structurally Distinct BET InhibitorHatice Gulcin Ozer, Dalia El-Gamal, Ben Powell, et al.
Pageof 4